Like many individuals round the world and in Brazil the place she lives, Parouhi Darakjian Kouyoumdjian grew to become contaminated with the coronavirus final yr; she had gentle signs and recovered. But her case is outstanding: Ms. Kouyoumdjian is a centenarian.
Still, whereas the aged usually tend to endure extreme and deadly instances of Covid-19, Ms. Kouyoumdjian just isn’t alone. She is a part of a examine led by Mayana Zatz, director of the Human Genome Research Center at the University of São Paulo, to know how very outdated individuals who grew to become contaminated with SARS-CoV-2 can emerge unscathed.
The scientists are genes from 15 centenarians — together with these of a 114-year-old girl who additionally recovered from Covid-19 — to see whether or not there are any mutations that supplied safety in opposition to the coronavirus.
“To survive until 114 years old is not easy, and to survive after having had Covid-19 is even more difficult,” Dr. Zatz stated. “I want to understand what makes someone survive.”
Throughout the pandemic, there have been numerous sorts of medical anomalies. There are individuals who check constructive for months and others who by no means get contaminated regardless of dwelling in shut quarters with Covid victims. Such shocking instances are sometimes declared “outliers” and shrugged off (and, certainly, ought to be downplayed when designing public well being insurance policies for the common inhabitants), however uncommon examples of any illness can supply vital insights for scientists, and most critically, result in new medicines for that sickness and others.
The sheer, devastating scale of the coronavirus unfold has additionally meant that there’s a distinctive alternative for researchers to advance data of the immune system.
One well-known instance of a remedy arising from somebody who’s seemingly impervious to a illness: Stephen Crohn, whose associate grew to become sick in 1978 with the illness later often known as AIDS, grew to become a beacon of hope for a brand new treatment. Mr. Crohn’s associate died, and so did lots of his buddies in the homosexual neighborhood, as H.I.V. unfold throughout the 1980s. But Mr. Crohn didn’t fall sick.
And when scientists tried to contaminate his cells in the lab with the virus, they couldn’t. A genetic mutation in a receptor on the floor of his cells made it unimaginable for the virus to enter them. That uncommon mutation, known as delta 32, impressed an antiviral drug known as maraviroc.
That’s not the solely time that distinctive genetic traits have impressed a brand new medication. Almost twenty years in the past, scientists uncovered an intriguing hyperlink between mutations in a specific gene to sky-high levels of cholesterol. They recognized the mutated gene in a handful of households the place many members had a situation known as hypercholesterolemia, a danger issue for coronary heart illness.
Ultimately, drug firms took discover and developed new medicine that focused the similar pathway as this gene that can be utilized to decrease ldl cholesterol even in folks with out the mutations. The first such treatment acquired approval in 2015.
Outliers can seem as solitary instances, however on this pandemic they’re usually bellwethers. In February 2020, simply as the pandemic started to speed up, a 71-year-old girl who was immunocompromised by a sort of most cancers that restricted her means to provide antibodies grew to become contaminated with the coronavirus at a Washington nursing dwelling. When scientists reported that she had examined constructive for the coronavirus for not less than 105 days and was infectious for not less than 70 days, it appeared like a unprecedented case. But since then, there have been quite a few instances of immunocompromised individuals who harbor the virus for months.
This, say the authors of 1 examine (which has not but been peer-reviewed) of one other immunocompromised man who examined constructive for greater than 300 days till handled with antibody medicine, gives proof that the department of the immune system that makes antibodies is important in preventing Covid-19.
Scientists have additionally discovered that the long-lasting infections seen in some sufferers with weakened immune methods gives a possibility for the virus to evolve, seemingly contributing to the rise of recent variants.
There have been instances of absolutely vaccinated people who find themselves wholesome and younger however nonetheless contract the virus in what’s often known as “breakthrough infections.” These instances too are outliers, albeit anticipated ones, since the vaccines are wonderful however not 100 p.c protecting. Identifying such people and finding out their immune response may present a window into what makes infections attainable after vaccination.
The insights about immunity gleaned from Covid-19 outliers may additionally assist scientists growing remedies and vaccines for different illnesses. For instance, a scarcity of safety from vaccination just isn’t an issue just for Covid-19.
Brianne Barker, a professor at Drew University in New Jersey who teaches virology and immunology, says that some individuals who obtain the hepatitis B vaccine, for instance, don’t appear to provide antibodies from it. “If we could understand why they aren’t responding, that could really help us understand the factors that allow for immune memory and vaccine protection,” Dr. Barker stated. Learning what components in the physique are likely to weaken immune responses may additionally assist scientists design remedies for autoimmune issues.
The immune system is intricate, with myriad totally different sorts of cells and molecules. “The complexity of the immune system cannot be overstated,” stated Kaitlyn Sadtler, an immunologist at the U.S. National Institute of Biomedical Imaging and Bioengineering who has studied Covid-19. “It makes it amazingly effective but amazingly difficult to understand.”
But research are beginning to present clues, together with one revealed final July that discovered genetic abnormalities in two pairs of younger brothers, aged 21 to 32, who had extreme Covid-19. The genetic modifications are recognized to impair the function of an vital immune system molecule known as interferon. A couple of months later, in September, one other paper in the journal Science recognized gene mutations affecting the interferon response in individuals who developed extreme Covid-19, together with younger adults, suggesting that giving these interferons to individuals who lack them may work as a remedy.
While figuring out the organic vulnerabilities that make some folks extra vulnerable to Covid-19’s wrath is beneficial, it’s equally vital to identify what immune system traits may make an individual stronger in opposition to the virus.
Science can study from each the happiest outcomes, and the most tragic. Each outlier is sort of a puzzle piece, and scientists want to search out and join greater than just some of them to get the huge image.
Ms. Khamsi is a science journalist overlaying the Covid-19 pandemic.
The Times is dedicated to publishing a range of letters to the editor. We’d like to listen to what you consider this or any of our articles. Here are some ideas. And right here’s our e mail: [email protected]
Follow The New York Times Opinion part on Facebook, Twitter (@NYTopinion) and Instagram.